Phase III Study of KX-826 With Adult Male Patients With AGA

Inclusion Criteria:

1. Agree to follow the study treatment regimen and visit plan, voluntarily enroll in thestudy, and sign the ICF in writing;
2. Male, ≥ 18 old;
3. Clinically diagnosed as androgenetic alopecia;
4. Rating IIIv, IV and V on Hamilton-Norwood scale;

Exclusion Criteria:

1. Have used androgen replacement therapy, immunosuppressants, corticosteroids and otherdrugs that may affect the efficacy evaluation within 3 months prior to screening;
2. Have used minoxidil within 6 months prior to screening;
3. Have used finasteride or dutasteride within 12 months prior to screening;
4. Had used topical drugs for alopecia sites within 3 months prior to screening;
5. Have received scalp radiation and/or laser or surgical therapy within 12 months priorto screening;
6. Those who, in the opinion of the investigator, have other conditions that may affectcompliance or are not suitable for participation in this study.